IvanPatrickMaillardMDPhD
Oncology • Philadelphia, PAHematologic Oncology
Professor of Medicine and Vice-Chief for Research, Division of Hematology/Oncology, University of Pennsylvania Perelman School of Medicine
Dr. Maillard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-615-5858- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2001 - 2005
University of Lausanne Faculty of MedicineClass of 1993
Certifications & Licensure
PA State Medical License 2001 - 2024
MI State Medical License 2007 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Mapping the Cellular Biogeography of Human Bone Marrow Niches Using Single-Cell Transcriptomics and Proteomic Imaging.Snaith, O. D., Shovik Bandyopadhyay, Michael Duffy, Kyung Jin Ahn, Minxing Pang, David Smith, Gwendolyn Duncan, Jonathan Sussman, Iris Zhang, Jeffrey Huang, Yulieh Lin...> ;Biorxiv. 2024 Mar 16
- Regulation of immune cell development, differentiation and function by stromal Notch ligands.Michael Schneider, Anneka Allman, Ivan Maillard> ;Current Opinion in Cell Biology. 2023 Dec 1
- 1 citationsIntrinsically disordered domain of transcription factor TCF-1 is required for T cell developmental fidelity.Naomi Goldman, Aditi Chandra, Isabelle Johnson, Matthew A Sullivan, Abhijeet R Patil, Ashley Vanderbeck, Atishay Jay, Yeqiao Zhou, Emily K Ferrari, Leland Mayne, Jenni...> ;Nature Immunology. 2023 Oct 1
- Join now to see all
Journal Articles
- Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-Exposure SARS-CoV-2 Prophylaxis Among Health Care WorkersMatthew C Hyman, Ian Frank, Scott E Hensley, Saar Gill, Dan T Vogl, Ivan Maillard, Daria V Babushok, Alexander C Huang, Sunita D Nasta, Jennifer C Walsh, Michael C Mil..., JAMA Internal Medicine
- The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid LeukemiaDale L Bixby, Ivan P Maillard, Moshe Talpaz, Leukemia Research
- Notch Signaling Mediated by Delta-like1/4 Ligands Controls the Pathogenesis of Chronic Graft-Versus-Host Disease in MiceIvan Maillard, Eric T Perkey, Maria A Pletneva, Stefanie Sarantopoulos, Bruce R Blazar, Vedran Radojcic, Blood
- Join now to see all
Abstracts/Posters
- Dll1 and Dll4 Notch Ligands Prime T Cell Alloimmunity and Are Expressed in Non-Overlapping Populations of Fibroblastic Stromal Cells in Spleen and Lymph Nodes at the O...Ivan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeIvan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- SETDB1 Mediated H3K9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic TransformationIvan Maillard, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Stromal Cell Immune Regulation in the Microenvironment61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The PAF1c Subunit Cdc73 Is Essential for Hematopoiesis and Displays Differential Gene Regulation in MLL-AF9 Driven Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- The Trithorax-Group Protein ASH1L Regulates Hematopoietic Stem Cell Homeostasis Independently of Its Histone Methyltransferase Activity2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Authored Content
- The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid LeukemiaJune 2018
Press Mentions
Genome Toxicity and Impaired Stem Cell Function After Conditional Activation of CreERT2 in the IntestineNovember 15th, 2018
1st-of-Its-Kind Therapy Blocks Immune Attack After Stem-Cell TransplantJanuary 23rd, 2024- Antibody Prevents Gastrointestinal GVHD Without Broad ImmunosuppressionJuly 1st, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- French, German, Portuguese
Hospital Affiliations
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
